Literature DB >> 1328202

Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysis.

A H Corbett1, R F DeVore, N Osheroff.   

Abstract

The catalytic activity of topoisomerase II is stimulated approximately 2-3-fold following phosphorylation by casein kinase II (Ackerman, P., Glover, C. V. C., and Osheroff, N. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 3164-3168). In order to delineate the mechanism by which the activity of the enzyme is enhanced, the effects of casein kinase II-mediated phosphorylation on the individual steps of the catalytic cycle of Drosophila topoisomerase II were characterized. Phosphorylation did not affect reaction steps that preceded hydrolysis of the enzyme's high energy ATP cofactor. This included enzyme-DNA binding, pre-strand passage DNA cleavage/religation, the double-stranded DNA passage event, and post-strand passage DNA cleavage/religation. In contrast, the rate of topoisomerase II-mediated ATP hydrolysis was stimulated 2.7-fold following phosphorylation by casein kinase II. Since ATP hydrolysis is a prerequisite for enzyme turnover, it is concluded that phosphorylation modulates the overall catalytic activity of topoisomerase II by stimulating the enzyme's ATPase activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328202

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.

Authors:  P S Shapiro; A M Whalen; N S Tolwinski; J Wilsbacher; S J Froelich-Ammon; M Garcia; N Osheroff; N G Ahn
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 2.  Casein kinase II in signal transduction and cell cycle regulation.

Authors:  D W Litchfield; B Lüscher
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

Review 3.  Structure and function of type II DNA topoisomerases.

Authors:  P M Watt; I D Hickson
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

Review 4.  The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance.

Authors:  Christophe Lotz; Valérie Lamour
Journal:  Cancer Drug Resist       Date:  2020-02-27

5.  Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.

Authors:  Katherine L West; Rosalind M Turnbull; Elaine Willmore; Jeremy H Lakey; Caroline A Austin
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

6.  Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast.

Authors:  Norihiko Nakazawa; Orie Arakawa; Masahiro Ebe; Mitsuhiro Yanagida
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

7.  The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells.

Authors:  Christine J Farr; Melissa Antoniou-Kourounioti; Michael L Mimmack; Arsen Volkov; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2014-01-29       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.